US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 18.340
- +0.830+4.74%
Close Nov 29 13:00 ET
- 18.340
- 0.0000.00%
Post 17:01 ET
496.78MMarket Cap-7871P/E (TTM)
18.615High17.545Low201.91KVolume17.670Open17.510Pre Close3.70MTurnover0.81%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.90P/B454.85MFloat Cap14.93052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM6.11%Amplitude4.110Historical Low18.317Avg Price1Lot Size
Arcturus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.52%38.82M | 380.67%45.98M | -59.11%32.6M | -23.33%157.75M | -84.33%25.08M | 224.45%43.38M | -64.70%9.57M | 1,420.39%79.73M | 1,564.82%205.76M | 2,662.32%160.05M |
| Operating revenue | -10.52%38.82M | 380.67%45.98M | -59.11%32.6M | -23.33%157.75M | -84.33%25.08M | 224.45%43.38M | -64.70%9.57M | 1,420.39%79.73M | 1,564.82%205.76M | 2,662.32%160.05M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -20.96%49.55M | 3.33%67.1M | -3.02%63.01M | 21.89%235.95M | 12.31%43.35M | 24.94%62.69M | 32.04%64.94M | 16.81%64.97M | -10.05%193.58M | -11.15%38.6M |
| Selling and administrative expenses | -0.76%13.28M | -6.87%12.32M | 7.91%14.85M | 14.76%52.87M | 5.46%12.51M | 7.12%13.38M | 20.30%13.23M | 28.26%13.76M | 11.15%46.07M | 9.75%11.86M |
| -General and administrative expense | -0.76%13.28M | -6.87%12.32M | 7.91%14.85M | 14.76%52.87M | 5.46%12.51M | 7.12%13.38M | 20.30%13.23M | 28.26%13.76M | 11.15%46.07M | 9.75%11.86M |
| Research and development costs | -23.38%39.13M | 11.39%58.67M | 3.49%53.57M | 30.04%192.13M | 35.73%36.62M | 35.53%51.08M | 37.91%52.67M | 15.31%51.77M | -14.97%147.75M | -17.32%26.98M |
| Other operating expenses | -62.02%-2.86M | -307.02%-3.88M | -873.74%-5.41M | -3,609.43%-9.05M | ---5.78M | ---1.76M | ---954K | ---556K | ---244K | ---- |
| Operating profit | 44.41%-10.74M | 61.85%-21.13M | -306.11%-30.41M | -742.24%-78.21M | -115.04%-18.27M | 47.53%-19.31M | -150.69%-55.37M | 129.29%14.76M | 106.00%12.18M | 422.62%121.45M |
| Net non-operating interest income expense | -4.33%7.64M | 27.55%4.15M | 62.13%4.02M | 4,050.48%16.59M | -450.34%-3.59M | 2,586.60%7.98M | 680.71%3.25M | 539.18%2.48M | 78.14%-420K | 295.61%1.03M |
| Non-operating interest income | -4.33%7.64M | 27.55%4.15M | 24.72%4.02M | 572.57%17.36M | -255.59%-2.82M | 1,697.75%7.98M | 1,835.71%3.25M | 1,990.91%3.22M | --2.58M | --1.82M |
| Non-operating interest expense | ---- | --0 | --0 | -74.44%767K | ---- | ---- | --0 | 3.48%743K | --3M | --790K |
| Other net income (expense) | -5,125.00%-201K | -360.40%-388K | -100.16%-53K | 3,130.01%33.72M | 98.59%-54K | -99.79%4K | -86.28%149K | 14,978.32%33.63M | -201.27%-1.11M | -676.32%-3.84M |
| Gain on sale of security | -5,125.00%-201K | -360.40%-388K | 83.84%-53K | 61.71%-229K | 98.59%-54K | -99.79%4K | -87.76%149K | -307.59%-328K | -202.40%-598K | -1,031.27%-3.84M |
| Earnings from equity interest | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-515K | --0 |
| Special income (charges) | --0 | --0 | --0 | --33.95M | --0 | --0 | --0 | --33.95M | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---33.95M | --0 | ---- | ---- | ---33.95M | ---- | ---- |
| Income before tax | 53.55%-7.12M | 66.59%-17.37M | -152.01%-26.45M | -362.03%-27.89M | -109.65%-11.45M | 56.53%-15.33M | -141.03%-51.97M | 199.39%50.86M | 105.23%10.64M | 406.86%118.64M |
| Income tax | -124.30%-217K | -126.00%-150K | 257.28%368K | 41.70%1.84M | -79.77%262K | 893K | 577K | 103K | 1.3M | 1.3M |
| Net income | 57.45%-6.9M | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M |
| Net income continuous Operations | 57.45%-6.9M | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 57.45%-6.9M | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 57.45%-6.9M | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M |
| Basic earnings per share | 57.38%-0.26 | 67.68%-0.64 | -152.36%-1 | -420.00%-1.12 | -107.22%-0.32 | 54.14%-0.61 | -141.46%-1.98 | 198.45%1.91 | 104.52%0.35 | 401.36%4.43 |
| Diluted earnings per share | 57.38%-0.26 | 67.68%-0.64 | -153.48%-1 | -420.00%-1.12 | -107.22%-0.32 | 54.14%-0.61 | -141.46%-1.98 | 196.39%1.87 | 104.52%0.35 | 401.36%4.43 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data